Evaluation of nepafenac in prevention of macular edema following cataract surgery in patients with diabetic retinopathy

BACKGROUND: The purpose of this study was to evaluate nepafenac ophthalmic suspension 0.1% (Nevanac(®); Alcon Research Ltd) in the prevention of macular edema following cataract surgery in diabetic retinopathy patients. METHODS: This was a multicenter, randomized, double-masked, vehicle-controlled s...

詳細記述

保存先:
書誌詳細
主要な著者: Singh, Rishi, Alpern, Louis, Jaffe, Glenn J, Lehmann, Robert P, Lim, John, Reiser, Harvey J, Sall, Kenneth, Walters, Thomas, Sager, Dana
フォーマット: Artigo
言語:Inglês
出版事項: Dove Medical Press 2012
主題:
Original Research
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3422154/
https://ncbi.nlm.nih.gov/pubmed/22927737
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OPTH.S31902
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料